Stevanato Group S.p.A. (STVN) Stock: Buy, Sell, or Hold?
STVN - Stevanato Group S.p.A.
$20.90
-0.05 (-0.24%)
âŧ
5d:
+1.75%
30d:
-1.65%
90d:
+20.88%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When STVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: STVN is fairly priced but lacks strong directional signals. At 3.4% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: STVN is fairly priced but lacks strong directional signals. At 3.4% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$32.61
Based on 11.7% avg growth
INTRINSIC VALUE TODAY
$20.25
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: STVN is currently trading at $20.90, which is considered fair relative to its 30-day fair value range of $20.32 to $21.93. From a valuation perspective, the stock is trading at a premium (Forward PE: 24.9) compared to its historical average (22.5). At these levels, the market is pricing in 3.4% annual earnings growth.
Technical Outlook: Technically, STVN is in a strong uptrend. Immediate support is located at $19.74, while resistance sits at $22.26.
Market Sentiment: STVN scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $24.83 (+18.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, STVN is in a strong uptrend. Immediate support is located at $19.74, while resistance sits at $22.26.
Market Sentiment: STVN scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $24.83 (+18.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$20.32 -
$21.93
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.0%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($24.83)
- BULLISH: Expecting earnings turnaround to 3.4% growth with 7.8% revenue growth
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$20.32 -
$21.93
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$19.74
Resistance Level
$22.26
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.87
Wall Street Target
$24.83
(+18.8%)
Revenue Growth (YoY)
7.8%
Earnings Growth (YoY)
-26.5%
Profit Margin
11.0%
Valuation Premium vs History
+3.4% premium
PE vs Historical
24.9 vs 22.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.4%
(market-implied from PE analysis)
1-Year Target
$21.61
(+3%)
2-Year Target
$22.35
(+7%)
3-Year Target
$23.11
(+11%)
3-Yr Target (if PE normalizes)
(PE: 25â23)
PE COMPRESSION
$20.90
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.9, Growth: 19.3%)
$35.51
(+70%)
Base:
(SPY PE: 20.2, Growth: 19.3%)
$28.80
(+38%)
Bear:
(PE: 17.1, Growth: 19.3%)
$24.48
(+17%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (36x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Trailing PE: 35.51 | Current EPS (TTM): $0.59
Bull Case
$32.83
(+57%)
Analyst growth 42.4%, PE expands to 39.1
Base Case
$29.84
(+43%)
Market implied 42.4%, PE stable at 35.5
Bear Case
$14.25
(-32%)
Severe decline -20.0%, PE contracts to 30.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 11, 2026 9:19 PM ET
Data refreshes hourly during market hours. Next update: 10:19 PM
Data refreshes hourly during market hours. Next update: 10:19 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 53 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 35 SELL |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
13 analysts |
$405 | 63 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$188 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 41 HOLD |
